CDKN2A and laryngeal neoplasm: Initially, it was thought that HPV did not play any part in larynx cancer but numbers of studies have demonstrated the presence of HPV and/or p16 marker (cyclin-dependent kinase inhibitor 2A/multiple tumor suppressor) in laryngeal tumors, although the biological and prognostic significance of this finding remains unclear.